Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Dusseldorf - Delayed Quote EUR

Ocuphire Pharma Inc (R3X1.DU)

Compare
0.8860
-0.0040
(-0.45%)
At close: March 10 at 4:00:16 PM GMT+1
Loading Chart for R3X1.DU
  • Previous Close 0.8900
  • Open 0.0000
  • Bid 0.8500 x --
  • Ask 0.8770 x --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 2.1150
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 8, 2025 - May 12, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: R3X1.DU

View More

Performance Overview: R3X1.DU

Trailing total returns as of 3/10/2025, which may include dividends or other distributions. Benchmark is S&P 500 .

YTD Return

R3X1.DU
18.42%
S&P 500
4.54%

1-Year Return

R3X1.DU
53.56%
S&P 500
9.58%

3-Year Return

R3X1.DU
71.42%
S&P 500
31.81%

5-Year Return

R3X1.DU
78.18%
S&P 500
94.80%

Compare To: R3X1.DU

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: R3X1.DU

View More

Valuation Measures

Annual
As of 3/7/2025
  • Market Cap

    29.22M

  • Enterprise Value

    -4.74M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.85

  • Price/Book (mrq)

    0.88

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: R3X1.DU

View More

Company Insights: R3X1.DU

Research Reports: R3X1.DU

View More